Rahul Rao

In June 2026, RBL Bank got everything a struggling lender could wish for. A Gulf banking giant wrote it a cheque for Rs 26,016 crore, its credit rating jumped four notches, and its stock had already climbed about 70% from the lows of the previous year. And yet, for FY26, it earned a Return on Assets (ROA) of just 0.55%. A healthy private bank earns 1.5% to 2%. RBL runs at roughly a third of that. RBL’s recovery So what did Emirates NBD (ENBD) actually buy?

Aarti Pharmalabs: 1-Year Stock Price Movement Source: http://www.tradingview.com Yet, despite a dream run at the bourses after getting demerged from Aarti Industries, the stock has fallen roughly 22% over the last year. What’s holding back the stock? Is the downtrend structural or simply a blip? Let’s dive in. Understanding the business Aarti Pharmalabs is not just a caffeine business.

Centum ended FY26 with a standalone order book of about Rs 1,645 crore, up 23%, giving revenue visibility for about a year and a half. (Image generated using AI) Centum Electronics ended FY26 with a reported net loss of nearly Rs 52 crore. On paper, that leaves the company with a negative price-to-earnings ratio. Yet the market appears to be telling a different story. The stock trades near Rs 3,634, up roughly 58% over the past year, and continues to trade near record highs.